Integrated CGT Hub The organization offers an integrated suite of services from clinical trial readiness to manufacturing, regulatory, health economics and market access, helping biotech partners move cell and gene therapy programs to clinic and commercialization in the UK. This positions CGT Catapult as a one-stop partner for startups and mid-sized biopharma seeking a simplified route to scale and market.

Funding Partnerships By collaborating with Innovate UK and engaging in government-backed funding programs, CGT Catapult can help clients access grants, subsidies, and funded programs to de-risk R&D and scale-up activities. Sales angle: position as gateway to UK public funding and partnerships to accelerate product development.

Data Driven With a tech stack including Databricks and Python, CGT Catapult can offer data analytics, trial data management, and process optimization services to support translational biology and CGT manufacturing. Opportunity to upsell data science, analytics, and digital workflow solutions for efficiency gains and faster time-to-market.

Leadership Momentum Ongoing leadership appointments indicate a strategic push toward enhanced business development, collaborations, and larger-scale programs. This suggests imminent opportunities for co-development, joint ventures, and long-term manufacturing partnerships with industry players seeking UK-based capabilities.

UK Gateway The Catapult's mission to make the UK the most compelling place to partner for UK and international players creates a sales channel for global biotech firms to enter UK clinical and manufacturing ecosystems, with potential services including regulatory navigation, supply chain design, and market access support.